🇺🇸 PCRX — Pacira BioSciences, Inc.

Salud Mantener
← Volver

Precio actual

36,39 USD

Máx. histórico

119,27

4269 días

Caída desde máximo

-69,49%

Rango 52 semanas

18,80 – 36,67

Variación hoy

-0,03%

Cierre anterior

36,40

Rango de hoy

36,39 – 36,41

Volumen hoy

1.075.323

Peor caída histórica

-90,19%

25/02/2015 → 09/08/2024

Aún sin recuperar

Volatilidad anualizada ⓘ

50,36%

Información
Nombre completo
Pacira BioSciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
825
PER ⓘ
103,97 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
33,57 USD (puede no estar actualizado)
Primera cotización
03/02/2011
Precio actualizado
hace 6 horas
Sobre la empresa

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension for postsurgical pain management; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension indicated for the management of osteoarthritis and knee pain; and iovera system, a non-opioid handheld cryoanalgesia device used to deliver controlled doses of cold temperature to targeted nerves to produce neurolytic block that interrupts the pain-transmitting signals of a peripheral nerve. It also develops PCRX-201, a novel gene therapy vector platform enabling local administration of genetic medicines with the potential to treat large prevalent diseases like osteoarthritis. It has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product for use in animals. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Brisbane, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
01/04/2013 28,77 29,03 27,16 28,56 -1,04% 6,50% 627.300
28/03/2013 28,49 28,93 28,19 28,86 -0,21% 2,60% 298.000
27/03/2013 28,68 29,06 28,17 28,92 +0,80% 3,10% 346.300
26/03/2013 28,52 29,00 28,34 28,69 +1,24% 2,31% 442.800
25/03/2013 27,62 28,75 27,60 28,34 +2,68% 4,16% 665.400
22/03/2013 27,50 27,78 27,24 27,60 +0,36% 1,96% 467.500
21/03/2013 27,37 27,50 26,77 27,50 +0,95% 2,67% 359.700
20/03/2013 27,26 27,50 26,64 27,24 +0,70% 3,15% 612.800
19/03/2013 28,17 28,29 26,51 27,05 -4,35% 6,32% 891.900
18/03/2013 29,54 29,60 27,70 28,28 -5,98% 6,43% 2.065.800
15/03/2013 30,00 30,94 29,75 30,08 +0,27% 3,97% 918.600
14/03/2013 29,44 30,21 29,23 30,00 +2,04% 3,33% 495.200
13/03/2013 29,01 29,78 28,18 29,40 +1,66% 5,52% 600.300
12/03/2013 29,01 29,57 28,04 28,92 -1,23% 5,27% 582.200
11/03/2013 28,20 30,11 27,82 29,28 +3,90% 8,12% 2.708.000
08/03/2013 26,42 28,45 26,42 28,18 +7,97% 7,68% 943.900
07/03/2013 26,05 26,25 24,72 26,10 +0,69% 5,87% 436.400
06/03/2013 25,54 26,38 25,18 25,92 +2,17% 4,70% 750.400
05/03/2013 24,01 25,48 23,71 25,37 +5,97% 7,37% 810.700
04/03/2013 23,42 23,94 23,12 23,94 +2,22% 3,50% 510.300
01/03/2013 21,74 23,75 21,43 23,42 +7,14% 10,67% 589.800
28/02/2013 21,68 21,98 21,36 21,86 +0,83% 2,86% 274.800
27/02/2013 21,00 21,95 20,73 21,68 +3,88% 5,81% 474.800
26/02/2013 20,52 21,16 20,52 20,87 +1,61% 3,12% 222.600
25/02/2013 20,50 20,89 20,32 20,54 -0,44% 2,78% 499.000
22/02/2013 20,48 20,63 20,15 20,63 +1,38% 2,34% 220.100
21/02/2013 20,31 20,43 20,02 20,35 -0,59% 2,02% 202.100
20/02/2013 20,00 20,70 19,91 20,47 +1,64% 3,95% 414.600
19/02/2013 19,85 20,26 19,67 20,14 +1,36% 2,97% 214.400
15/02/2013 20,00 20,00 19,67 19,87 +0,71% 1,65% 131.100